Renovaro Biosciences
RENB
#7734
Rank
S$0.35 B
Marketcap
$2.23
Share price
6.15%
Change (1 day)
-48.33%
Change (1 year)

Renovaro Biosciences (RENB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$32.21 Million

According to Renovaro Biosciences's latest financial reports the company's total liabilities are S$32.21 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Renovaro Biosciences - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30S$16 M-4.36%
2022-06-30S$16.73 M-16.73%
2021-06-30S$20.09 M21.9%
2020-06-30S$16.48 M79.78%
2019-06-30S$9.16 M-71.69%
2018-06-30S$32.38 M686.02%
2017-06-30S$4.12 M102.9%
2016-06-30S$2.03 M
2014-12-31S$2.32 M
2013-03-31S$0.08 M158.2%
2012-03-31S$0.03 M210.73%
2011-03-31S$0.01 M